Literature DB >> 7955434

Whole body composition and regional bone mass in women with insulin-dependent diabetes mellitus.

J E Compston1, E M Smith, C Matthews, P Schofield.   

Abstract

OBJECTIVE: Reduced bone mass has been reported in adult patients with insulin-dependent diabetes mellitus but there are few data on bone density in the axial skeleton or on whole body composition in this group. The aim of this study was to determine whether whole body and regional bone mass are normal in middle-aged women with insulin-dependent diabetes mellitus.
DESIGN: Total and regional bone mass were measured in 24 post-menopausal women aged 43-69 years (mean 56.3) with insulin-dependent diabetes, recruited during routine clinic attendance. Results were compared with those obtained from 24 age and weight-matched community-based post-menopausal women. MEASUREMENTS: Whole body bone mineral content and bone mass in the lumbar spine and femoral neck were measured by dual energy X-ray absorptiometry on a Lunar DPX.
RESULTS: Whole body bone mineral content was significantly lower in the diabetic women than in community-based controls (P = 0.02). There was no significant difference between the two groups in whole body bone density or lumbar spine bone density. Mean bone density in the femur was lower in the patient group at all sites assessed (femoral trochanter P = 0.003, femoral neck, P = 0.057). Values for all regional bone density measurements in the diabetic women were within the Lunar reference range (mean +/- 2 SD) and at all sites the mean value was close to 100% of the sex and age-matched reference value. There was no correlation between duration or control of diabetes and bone mass at any site.
CONCLUSIONS: Insulin-dependent diabetes mellitus in middle-aged women is associated with small reductions in total body bone mineral content and in femoral bone density; the clinical significance of these findings in terms of subsequent fracture risk remains to be established. No evidence was found in this study for a reduction in whole body or lumbar spine bone density.

Entities:  

Mesh:

Year:  1994        PMID: 7955434     DOI: 10.1111/j.1365-2265.1994.tb02547.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  8 in total

1.  Deletion of FoxO1, 3, and 4 in Osteoblast Progenitors Attenuates the Loss of Cancellous Bone Mass in a Mouse Model of Type 1 Diabetes.

Authors:  Srividhya Iyer; Li Han; Elena Ambrogini; Maria Yavropoulou; John Fowlkes; Stavros C Manolagas; Maria Almeida
Journal:  J Bone Miner Res       Date:  2016-09-07       Impact factor: 6.741

Review 2.  Bone, sweet bone--osteoporotic fractures in diabetes mellitus.

Authors:  Christine Hamann; Stephan Kirschner; Klaus-Peter Günther; Lorenz C Hofbauer
Journal:  Nat Rev Endocrinol       Date:  2012-01-17       Impact factor: 43.330

Review 3.  Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis.

Authors:  P Vestergaard
Journal:  Osteoporos Int       Date:  2006-10-27       Impact factor: 4.507

4.  Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology.

Authors:  S A Kemink; A R Hermus; L M Swinkels; J A Lutterman; A G Smals
Journal:  J Endocrinol Invest       Date:  2000-05       Impact factor: 4.256

5.  Bone mineral density measured by dual X-ray absorptiometry in Spanish patients with insulin-dependent diabetes mellitus.

Authors:  M Muñoz-Torres; E Jódar; F Escobar-Jiménez; P J López-Ibarra; J D Luna
Journal:  Calcif Tissue Int       Date:  1996-05       Impact factor: 4.333

6.  Increase in Bone Mass Before Onset of Type 1 Diabetes Mellitus in Rats.

Authors:  Lyubomir Haralambiev; Andreas Nitsch; Cornelius S Fischer; Anja Lange; Ingrid Klöting; Matthias B Stope; Axel Ekkernkamp; Jörn Lange
Journal:  In Vivo       Date:  2022 May-Jun       Impact factor: 2.406

7.  Evaluation of bone density measurement in type 2 diabetic postmenopausal women with hypertension and hyperlipidemia.

Authors:  Emel Kiyak Caglayan; Yaprak Engin-Ustun; Nagihan Sari; Seyhan Karacavus; Levent Seckin; Mustafa Kara
Journal:  J Menopausal Med       Date:  2015-04-27

8.  Prevalence and determinants of osteoporosis in patients with type 1 and type 2 diabetes mellitus.

Authors:  Gudrun Leidig-Bruckner; Sonja Grobholz; Thomas Bruckner; Christa Scheidt-Nave; Peter Nawroth; Jochen G Schneider
Journal:  BMC Endocr Disord       Date:  2014-04-11       Impact factor: 2.763

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.